CD105 Expression Is a Marker of High Metastatic Risk and Poor Outcome in Breast Carcinomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD105 Expression Is a Marker of High Metastatic Risk and Poor Outcome in Breast Carcinomas

Published:2003-03 Issue:3 Volume:119 Page:374-380
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Dales Jean-Philippe,Garcia Stephane,Bonnier Pascal,Duffaud Florence,Andrac-Meyer Lucile,Ramuz Olivier,Lavaut Marie-Noëlle,Allasia Claude,Charpin Colette

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/119/3/374/4985772/ajcpath119-0374.pdf

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumoral CD105 promotes immunosuppression, metastasis, and angiogenesis in renal cell carcinoma;Cancer Immunology, Immunotherapy;2022-12-31

2. Identification of CD105 (endoglin) as novel risk marker in CLL;Annals of Hematology;2022-01-19

3. Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment;Nutrients;2021-12-25

4. Evaluation of CDCP1 (CD318) and endoglin (CD105) expression as prognostic markers in acute myeloid leukemia;Cancer Biomarkers;2021-12-17

5. Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer;Materials Today;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP